文章名稱引用次數(shù)

• Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y(12) Receptor Inhibitor Treatment in Percutaneous Coronary Intervention73
• A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism The OPTALYSE PE Trial46
• Outcomes After Current Transcatheter Tricuspid Valve Intervention Mid-Term Results From the International TriValve Registry46
• Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention46
• The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low Medium and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers The 3M TAVR Study42
• Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement Concept to First-in-Human40
• The BASILICA Trial Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction39
• A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism The FLARE Study38
• Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement37
• Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes Insights From the TVT Registry33